NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

STERIS plc (STE) Stock Analysis

STERIS plc (STE) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

STE

$224.59

−$2.24 (−0.99%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare STE with… →

STE Key Statistics

As of Sep 4, 2026
Trading
Open
$223.20
Previous Close
$226.83
Day's Range
221.44–225.44
52-Week Range
195.14–269.44
Volume
568.00K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$21.90B
P/E Ratio
27.42
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.34
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.89
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.63
EPS (ttm)Profit attributable to each share over the last twelve months.
8.19
Financials (FY)
Revenue (FY)
$5.94B+8.73%
Net Income (FY)
$782.30M+27.27%
Profit marginThe share of revenue left as profit after all costs and taxes.
13.33%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
97.50M
1-Year Return
−7.21%
Dividend and dates
Dividend
$2.58+1.14%
Ex-Dividend Date
September 4, 2026
Earnings Date
November 4, 2026estimated
Avg Volume
747.74K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

STE Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−10.92%
2025+24.26%
2024−5.60%
2023+20.19%
2022−23.43%
2021+29.47%
2020+25.50%
2019+44.09%
2018+23.66%
2017+31.73%
2016 (partial year)−6.38%

As of September 4, 2026.

STE Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$5.94B$782.30M13.2%
2024$5.46B$614.70M11.3%
2023$5.14B$378.30M7.4%
2022$4.54B$107.03M2.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$5.94B$2.63B$1.11B$782.30M13.2%
2024$5.46B$2.40B$960.90M$614.70M11.3%
2023$5.14B$2.22B$862.20M$378.30M7.4%
2022$4.54B$1.98B$791.59M$107.03M2.4%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

STE Dividend History

$1.77−18.8% vs 2024

Dividends per share, 2025 · 3 payments

YearDividends per sharePaymentsChange
2026*$1.953—
2025$1.773−18.8%
2024$2.184+10.1%
2023$1.984+10.0%
YearDividends per sharePaymentsChange
2026 (partial year)$1.953—
2025$1.773−18.8%
2024$2.184+10.1%
2023$1.984+10.0%
2022$1.804+8.4%
2021$1.664+7.8%
2020$1.544+8.5%
2019$1.424+9.2%
2018$1.304+10.2%
2017$1.184+321.4%
2016$0.281—

Most recent payment: $0.65 per share, ex-dividend September 4, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

STE Valuation vs Medical Devices Median

Median of 151 stocks
MetricSTEMedical Devices medianvs median
P/E27.4226.802% above
P/S ratio3.632.9822% above
Profit margin13.33%−1.69%15.0 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values STERIS plc (STE) at $21.90B. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 17,937 employees.

The most recent close on file for STE is $224.59, dated September 4, 2026. That is −$2.24 (−0.99%) against the previous close. Over the past 52 weeks the price has ranged from $195.14 to $269.44. The latest close sits 15.09% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $5.94B. Against the prior fiscal year total of $5.46B, that is a change of +8.73%. Net income for the same year was $782.30M. That is +27.27% against the prior fiscal year. The reported profit margin is 13.33%. That is 15 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 8.19.

Across the 4 fiscal years on file, revenue moves from $4.54B in 2022 to $5.94B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 27.42. That is 2.31% above the Medical Devices median of 26.8. On forward earnings the ratio is 18.34. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.89. Measured against sales, the shares trade at 3.63 times revenue. On price-to-sales that is 21.87% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −7.21%. Measured over 10 years, that is +13.33% a year compounded. The reported beta is 0.91. Daily returns over the trailing 10 years annualize to a volatility of 25.17%.

Growth & Income

STE pays a dividend yielding 1.14%. That is 0.2 percentage points below the Medical Devices median yield of 1.38%. At the indicated rate that is $2.58 a share a year. The ex-dividend date on file is September 4, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.95 a share. The year before, 2025, totalled $1.77 a share.

The strongest complete calendar year on file is 2019 at +44.09%; the weakest is 2022 at −23.43%. Of the 9 complete calendar years on file, 7 finished higher. 2026 is still running; the price is −10.92% year to date.

Peer Comparison

STERIS plc (STE) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
STERIS plc STE $21.90B 27.4
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. STERIS plc trades at a P/E of 27.4.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Visit website →